The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Endocrine Practice

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP.4.5.259PMID 15251721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors

  2004cited by this paper
• Tumor Necrosis Factor-α in Sera of Obese Patients: Fall with Weight Loss

  1998cited by this paper
• Glycemic Control and the Risk for Coronary Heart Disease in Patients with Non-Insulin-dependent Diabetes Mellitus: The Finnish Studies

  1996cited by this paper
• Body weight and mortality.

  1995cited by this paper
• Obesity and cancer.

  1995cited by this paper
• Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM

  1994cited by this paper
• Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groups

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

  1991cited by this paper
• Standards of Medical Care for Patients With Diabetes Mellitus

  1989cited by this paper
• [Latex-agglutination immunoassay].

  1986cited by this paper
• The clinical information value of the glycosylated hemoglobin assay.

  1984cited by this paper
• Diarrhea and Metformin in a Diabetic Clinic

  1983cited by this paper
• A glucose dehydrogenase for determination of glucose concentrations in body fluids

  1975cited by this paper

• Managing Type 2 Diabetes: Balancing HbA1c and Body Weight

  2010cites this paper
• Is β-cell failure in type 2 diabetes mellitus reversible?

  2008cites this paper
• Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?

  2007cites this paper
• Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes.

  2006cites this paper
• Use of Continuous Subcutaneous Insulin Infusion Pump in Patients With Type 2 Diabetes Mellitus

  2005cites this paper
• The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.

  2003cites this paper
• Efficacy of Sulfonylureas with Insulin in Type 2 Diabetes Mellitus

  2003cites this paper
• Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.

  2000cites this paper
• Benefits and Risks of Transfer from Oral Agents to Insulin in Type 2 Diabetes Mellitus

  1999cites this paper
• Metformin in der Diabetestherapie

  1998cites this paper
• Diagnostic and Therapeutic Considerations in Adults with Diabetes Mellitus Case Studies

  year unknowncites this paper